Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine

Current HIV Research

Volumn 7, Issue 2, 2009, Pages 211-217

  Pornprasert, Sakorn ^a   Mary, Jean Yves ^b   Faye, Albert ^b,i   Leechanachai, Pannee ^a   Limtrakul, Aram ^c   Rugpao, Sungwal ^d,s   Sirivatanapa, Pannee ^d,u   Gomuthbutra, Vorapin ^e   Matanasaravoot, Wanmanee ^f   Le Cœur, Sophie ^g   Lallemant, Marc ^h,o   Barré Sinoussi, Françoise ⁱ   Menu, Elisabeth ⁱ   Ngo Giang Huong, Nicole ^h,r   Ayouba, Ahidjo ⁱ   Chailert, Sanupong ^j   Chaouat, Gérard ^k   Derrien, Muriel ^k   Dolcini, Guillermina ^l   Eteki, Nicole ^m   Kfutwah, Anfumbom Jude ⁿ   Kouo, Odette ^o   Lemen, Brigitte ^o   Maldonado Estrada, Juan ^p   Nerrienet, Eric ^q   Njinku, Bernadette ⁿ   Scarlatti, Gabriella ^t   Tejiokem, Mathurin ⁿ   Téné, Gilbert ^v   more..

^a CHIANG MAI UNIVERSITY   (Thailand)

^b INSERM   (France)

^c Health Promotion Center   (Thailand)

^d Faculty of Medicine Chiang Mai University   (Thailand)

^e NAKORNPING HOSPITAL   (Thailand)

^f Lamphun Hospital   (Thailand)

^g INSTITUT NATIONAL D'ÉTUDES DÉMOGRAPHIQUES   (France)

^h INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

ⁱ INSTITUT PASTEUR   (France)

^j PHPT   (Thailand)

^k INSTITUT COCHIN   (France)

^l UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^m Hopital Central de Yaounde   (Cameroon)

ⁿ CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^o Centre de Santé Mgr J Zoa Nkolndongo   (Cameroon)

^p UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^q INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

^r HSPH   (Thailand)

^s Maharaj Nakorn Chiang Mai Hospital   (Thailand)

^t SAN RAFFAELE HOSPITAL   (Italy)

^u Suandok Hospital   (Thailand)

^v Centre Mere et Enfant   (Cameroon)

more..

Author keywords

Antiretroviral prophylaxis; HIV 1; IL 10 cytokine; Mother to child transmission; Placenta; Zidovudine and nevirapine

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 8; MESSENGER RNA; NEVIRAPINE; PLACEBO; RANTES; TUMOR NECROSIS FACTOR ALPHA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MOTHER TO CHILD TRANSMISSION; PLACENTA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; ARTICLE; BIOSYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TIME; VIROLOGY;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-10; NEVIRAPINE; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TIME FACTORS; YOUNG ADULT; ZIDOVUDINE;

EID: 64749097199     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209787581472     Document Type: Review

References (30)

1. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: a review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992; 15: 678-91.
2. Zachar V, Norskov-Lauritsen N, Juhl C, Spire B, Chermann JC, Ebbesen P. Susceptibility of cultured human trophoblasts to infection with human immunodeficiency virus type 1. J Gen Virol 1991; 72: 1253-60.
3. Zachar V, Spire B, Hirsch I, Chermann JC, Ebbesen P. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol 1991; 65: 2102-7.
4. Dolcini G, Derrien M, Chaouat G, Barre-Sinoussi F, Menu E. Cellfree HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses 2003; 19: 857-64.
5. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta-the role of malaria. Placenta 2004; 25: 359-78.
6. Rogerson SJ, Brown HC, Pollina E, et al. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun 2003; 71: 267-70.
7. Fievet N, Moussa M, Tami G, et al. Plasmodium falciparum induces a Th1/Th2 disequilibrium, favoring the Th1-type pathway, in the human placenta. J Infect Dis 2001; 183: 1530-4.
8. Reuben JM, Gonik B, Li S, Loo L, Turpin J. Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine Cytokine Res 1991; 10: 195-9.
9. Reuben JM, Turpin JA, Lee BN, et al. Induction of inflammatory cytokines in placental monocytes of gravidae infected with the human immunodeficiency virus type 1. J Interferon Cytokine Res 1996; 16: 963-71.
10. Gallagher M, Malhotra I, Mungai PL, et al. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. Aids 2005; 19: 1849-55.
11. Vidricaire G, Tardif MR, Tremblay MJ. The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1. J Biol Chem 2003; 278: 15832-41.
12. Zachar V, Fink T, Koppelhus U, Ebbesen P. Role of placental cytokines in transcriptional modulation of HIV type 1 in the isolated villous trophoblast. AIDS Res Hum Retroviruses 2002; 18: 839-47.
13. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
14. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIV-NET012 randomised trial. Lancet 1999; 354: 795-802.
15. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351: 217-28.
16. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1996; 335: 1621-9.
17. Musoke P, Guay LA, Bagenda D, et al. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). Aids 1999; 13: 479-86.
18. Faye A, Pornprasert S, Mary JY, et al. Characterization of the main placental cytokine profiles from HIV-1-infected pregnant women treated with anti-retroviral drugs in France. Clin Exp Immunol 2007; 149: 430-9.
19. Taupin JL, Gualde N, Moreau JF. A monoclonal antibody based elisa for quantitation of human leukaemia inhibitory factor. Cytokine 1997; 9: 112-8.
20. Mirochnick M, Fenton T, Gagnier P, et al. Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis 1998; 178: 368-74.
21. Pornprasert S, Faye A, Mary JY, et al. Down modulation of TNF-alpha mRNA placental expression by AZT used for the prevention of HIV-1 mother-to-child transmission. Placenta 2006; 27: 989-95.
22. Schramm DB, Kuhn L, Gray GE, Tiemessen CT. In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr 2006; 42: 545-53.
23. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-20.
24. Knolle PA, Uhrig A, Protzer U, et al. Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells. Hepatology 1998; 27: 93-9.
25. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184: 539-48.
26. Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. Aids 2008; 22: 289-99.
27. Than S, Hu R, Oyaizu N, et al. Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children. J Infect Dis 1997; 175: 47-56.
28. Breen EC. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther 2002; 95: 295-304.
29. Behbahani H, Popek E, Garcia P, et al. Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission. Am J Pathol 2000; 157: 1811-8.
30. Ghosh SK, Wood C, Boise LH, et al. Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 2003; 101: 2321-7.